Log in
Enquire now
Tallac Therapeutics

Tallac Therapeutics

Tallac Therapeutics is a novel Cancer Immunotherapies.

OverviewStructured DataIssuesContributors

Contents

tallactherapeutics.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Biomedical engineering
Biomedical engineering
Engineering
Engineering
Biotechnology
Biotechnology
Biopharmaceutical
Biopharmaceutical
Location
San Francisco
San Francisco
B2X
B2B
B2B
0
Number of Employees (Ranges)
11 – 500
Email Address
info@tallactx.com
Investors
Morningside Venture Partners
Morningside Venture Partners
Matrix Partners China
Matrix Partners China
Lightstone Ventures
Lightstone Ventures
MRL Ventures
MRL Ventures
venBio
venBio
Total Funding Amount (USD)
62,000,000
Latest Funding Round Date
December 2020
Latest Funding Type
Series A
Series A
Patents Assigned (Count)
1
Country
United States
United States
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Tallac Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.